The diagnosis and treatment of venous thromboembolism in Asian patients

Abstract

Although the incidence of venous thromboembolism (VTE) in Asian populations is lower than in Western countries, the overall burden of VTE in Asia has been considerably underestimated. Factors that may explain the lower prevalence of VTE in Asian populations relative to Western populations include the limited availability of epidemiological data in Asia, ethnic differences in the genetic predisposition to VTE, underdiagnoses, low awareness toward thrombotic disease, and possibly less symptomatic VTE in Asian patients. The clinical assessment, diagnostic testing, and therapeutic considerations for VTE are, in general, the same in Asian populations as they are in Western populations. The management of VTE is based upon balancing the treatment benefits against the risk of bleeding. This is an especially important consideration for Asian populations because of increased risk of intracranial hemorrhage with vitamin K antagonists. Non-vitamin K antagonist oral anticoagulants have shown advantages over current treatment modalities with respect to bleeding outcomes in major phase 3 clinical trials, including in Asian populations. Although anticoagulant therapy has been shown to reduce the risk of postoperative VTE in Western populations, VTE prophylaxis is not administered routinely in Asian countries. Despite advances in the management of VTE, data in Asian populations on the incidence, prevalence, recurrence, risk factors, and management of bleeding complications are limited and there is need for increased awareness. To that end, this review summarizes the available data on the epidemiology, risk stratification, diagnosis, and treatment considerations in the management of VTE in Asia.

Safety of baricitinib in East Asian patients with moderate‐to‐severe active rheumatoid arthritis: An integrated analysis from clinical trials

“…The risks of developing DVT and PE in patients with RA compared with those of the general population are 3‐fold and 2‐fold, respectively . The incidence of venous thromboembolism has increased in Asia in recent times but generally remains lower than in Western countries . In this analysis, there were no cases of PE reported; 4 cases of DVT were reported in EA patients with predisposing risk factors, such as obesity, history of surgery, DVT, trauma, or decreased mobility.…”

XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America

“…Furthermore, some Asian guidelines (e.g. Japan) advise targeting the lower INR range for this reason [15,16]. This approach was reflected in the higher TTR (50.9%) when an INR for the target range of 1.5-2.5 was considered in the analysis of patients from the Asia-Pacific region.…”

Epidemiology of Venous Thrombo-Embolic Disease in Yaounde: A Cross-Sectional Study in Sub-Saharan Africa

“…This cross-sectional study aimed to describe the epidemiology, clinical presenta- [22]. This racial disparity was described before by Zakai et al, may be due to lifestyle, diet (less obesity), and disease predominance [23].…”